Molecular diagnostics of malignant melanoma: Molecular staging, minimal residual disease;A malignus melanoma molekuláris diagnosztikája: Molekuláris stádiummeghatározás, minimális reziduális betegség

Magyar Onkologia

Volumn 47, Issue 1, 2003, Pages 63-66

  József, Tímár ^a   Orsolya, Csuka ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; HUMAN; MELANOMA; METASTASIS; MINIMAL RESIDUAL DISEASE; PATHOLOGY; POLYMERASE CHAIN REACTION; REVIEW; SKIN TUMOR; TUMOR EMBOLISM;

HUMANS; MELANOMA; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 0043203060     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bertucci F, Houlgatte R, Nguyen C, et al. Gene expression profiling of cancer by use of DNA arrays: how far from the clinic? Lancet Oncol 2:674-682, 2001
2. Biegliek SC, Ghossein RA, Bhattacharya S, Coi DG. Detection of tyrosinase mRNA by reverse transcriptase polymerase chain reaction (RT-PCR) in melanoma sentinel nodes. Ann Surg Oncol 6:232-240,1999
3. Bishop JAN. Molecular pathology of melanoma. Cancer Metastasis Rev 16:141-154, 1997
4. Blaeta HJ, Paul T, Sotlar K, et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol 145:195-202, 2001
5. Brossart P, Schmier J-W, Krüger S, et al. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55:4065-4068, 1995
6. Carrillo E, Prados J, Melguizo C, et al. Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: correlation with clinical stage, tumor thickness and histological type. Pathol Int 52:294-299, 2002
7. Cserni G. Melanoma malignumos betegek sentinel nyirokcsomóinak patológiai vizsgálata. Magyar Onkológia 47:51-57, 2003
8. Curry BJ, Myers K, Hersy P. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases. J Clin Oncol 17:2562-2571, 1999
9. Davids V, Kidson SH, Hanekom GS. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate. Mol Pathol 56:43-51, 2003
10. Farthman B, Eberle J, Krasagakis K, et al. RT PCR for tyrosinase mRNA positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 110:263-267, 1998
11. Fodstad O, Faye R, Hoiford HK, et al. Immunobeadbased detection and characterization of circulating tumor cells in melanoma patients. Recent Results Cancer Res 158:40-50, 2001
12. Georgieva J, Milling A, Orfanos CE, Geilen CC. Magnetic bead RT-PCR: establishment of a new method for detecting circulating melanoma cells. Melanoma Res 12:309-317, 2002
13. Ghossein RA, Coit D, Brennan M, et al. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 4:419-428, 1998
14. Gogas H, Kefala G, Bafaloukos D, et al. Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon. Br J Cancer 87:181-186, 2002
15. Hoon DSB, Wang Y, Dale PS, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116, 1995
16. Kaplan JC, Kahn A, Chelly J. Illegitimate transcription: its use in the study of inherited disease. Hum Mutat 1:357-360, 1992
17. Kunter U, Buer J, Probst M. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88:590-594, 1996
18. Ladanyi M, Chan WC, Triche TJ, Gerald, WL. Expression profiling of human tumors: the end of surgical pathology? J Mol Diagnostics 3:92-97, 2001
19. Max N, Keilholz U. Minimal residual disease in melanoma. Semin Surg Oncol 20:319-328, 2001
20. Mellado B, Guttierrez L, Castel T, et al. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients. Clin Cancer Res 5:1843-1848, 1999
21. Neumaier M, Gerhard M, Wagener C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 159:43-47, 1995
22. Papa R. Bone marrow metastases. A review. Cancer 74:2403-2413, 1994
23. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24:227-235, 2000
24. Ruiter DJ, Spatz A, van den Oord JJ, Cook MG. Microstaging in cutaneous melanoma. J Pathol 195:525-529, 2001
25. Schmidt H, Sorensen BS, von der Maase H, et al. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma. Melanoma Res 12:585-592, 2002
26. Strohal R, Mosser R, Kittler H, et al. MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical state and disease progression. Melanoma Res 11:543-548, 2001
27. Takeuchi H, Kuo C, Morton DL, et al. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advancedstage melanomas. Cancer Res 63:441-448, 2003
28. Tímár J, Csuka O, Orosz Zs, et al. Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis. Pathol Oncol Res 8:204-219, 2002
29. Tsao H, Nadiminti U, Sober AJ, Bigby M. A metaanalysis of reverse transcriptase-polymerase chain reaction for tyrosine mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch Dermatol 137:325-330, 2001
30. Warr RP, Zebedee Z, Kenealy J, et al. Detection of melanoma seeding during surgical procedures-an RTPCR based model. Eur J Surg Oncol 28:832-837, 2002